(Q33781604)

29 July 2017

1 reference

title

Elevated oxidative stress in models of normal brain aging and Alzheimer's disease (English)

1 reference

29 July 2017

0 references

Butterfield DA

1

1 reference

29 July 2017

Howard B

2

1 reference

29 July 2017

Yatin S

3

1 reference

29 July 2017

Koppal T

4

1 reference

29 July 2017

Drake J

5

1 reference

29 July 2017

Hensley K

6

1 reference

29 July 2017

Aksenov M

7

1 reference

29 July 2017

Aksenova M

8

1 reference

29 July 2017

Subramaniam R

9

1 reference

29 July 2017

Varadarajan S

10

1 reference

29 July 2017

Harris-White ME

11

1 reference

29 July 2017

Pedigo NW Jr

12

1 reference

29 July 2017

Carney JM

13

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

29 July 2017

1 reference

29 July 2017

65

1 reference

29 July 2017

18-19

1 reference

29 July 2017

1883-1892

1 reference

Free radical involvement in aging. Pathophysiology and therapeutic implications

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Protein oxidation and aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Carbonyl assays for determination of oxidatively modified proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Oxidative modification of glutamine synthetase by amyloid beta peptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Derivatization of gamma-glutamyl semialdehyde residues in oxidized proteins by fluoresceinamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Determination of carbonyl groups in oxidatively modified proteins by reduction with tritiated sodium borohydride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Electron paramagnetic resonance investigations of free radical-induced alterations in neocortical synaptosomal membrane protein infrastructure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Ischemia/reperfusion-induced changes in membrane proteins and lipids of gerbil cortical synaptosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Prevention of ischemia/reperfusion-induced alterations in synaptosomal membrane-associated proteins and lipids by N-tert-butyl-alpha-phenylnitrone and difluoromethylornithine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Structural alterations in synaptosomal membrane-associated proteins and lipids by transient middle cerebral artery occlusion in the cat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Effect of 2-cyclohexene-1-one-induced glutathione diminution on ischemia/reperfusion-induced alterations in the physical state of brain synaptosomal membrane proteins and lipids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Menadione-induced cytotoxicity effects on human erythrocyte membranes studied by electron paramagnetic resonance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Effect of lipopolysaccharide on the physical conformation of the erythrocyte cytoskeletal proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Modification of hepatic proteins in rats exposed to high oxygen concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Protein oxidation and proteolysis during aging and oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Prevention of hyperoxia-induced alterations in synaptosomal membrane-associated proteins by N-tert-butyl-alpha-phenylnitrone and 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl (Tempol).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

The spin-trap N-tert-alpha-phenyl-butylnitrone prolongs the life span of the senescence accelerated mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Advances in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Amyloid beta-protein and the genetics of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Studies on the origin of the hydroxyl spin adduct of DMPO produced from the stimulation of neutrophils by phorbol-12-myristate-13-acetate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer's disease-associated amyloid beta peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Amyloid beta peptide (25-35) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

beta-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Staurosporine and K-252 compounds protect hippocampal neurons against amyloid beta-peptide toxicity and oxidative injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

K+ channel openers protect hippocampal neurons against oxidative injury and amyloid beta-peptide toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical and calcium accumulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

The acute neurotoxic effect of beta-amyloid on mature cultures of rat hippocampal neurons is attenuated by the anti-oxidant U-78517F.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Inhibition of age-induced beta-amyloid neurotoxicity in rat hippocampal cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

beta-Amyloid-induced toxicity in rat hippocampal cells: in vitro evidence for the involvement of free radicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Alzheimer's disease amyloid beta peptide 25-35 is localized in the membrane hydrocarbon core: x-ray diffraction analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

4-Hydroxynonenal, an aldehydic product of lipid peroxidation, impairs signal transduction associated with muscarinic acetylcholine and metabotropic glutamate receptors: possible action on G alpha(q/11).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Bcl-2 protects isolated plasma and mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid beta-peptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Oxidative stress hypothesis in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Oxidative stress and Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Mitochondria, free radicals, and neurodegeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Enhanced phosphodiestric breakdown of phosphatidylinositol bisphosphate after experimental brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900442-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0024-3205(99)00442-7

1 reference

29 July 2017

1 reference